Article Versions Notes

Kresoja-Rakic J, Szpechcinski A, Kirschner MB, Ronner M, Minatel B, Martinez VD, Lam WL, Weder W, Stahel R, Früh M, et al. miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery. Non-Coding RNA. 2019; 5(2):41. https://doi.org/10.3390/ncrna5020041

Kresoja-Rakic, Jelena, Adam Szpechcinski, Michaela B. Kirschner, Manuel Ronner, Brenda Minatel, Victor D. Martinez, Wan L. Lam, Walter Weder, Rolf Stahel, Martin Früh, and et al. 2019. "miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery" Non-Coding RNA 5, no. 2: 41. https://doi.org/10.3390/ncrna5020041

Kresoja-Rakic, J., Szpechcinski, A., Kirschner, M. B., Ronner, M., Minatel, B., Martinez, V. D., Lam, W. L., Weder, W., Stahel, R., Früh, M., Cerciello, F., & Felley-Bosco, E. (2019). miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery. Non-Coding RNA, 5(2), 41. https://doi.org/10.3390/ncrna5020041